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Abstract 
The protein kinase C (PKC) family consists of a number of closely related isotypes, whose in vivo phosphorylation state is regulated 
in a dynamic fashion by the enzyme's activators. We have investigated here the changes in PKC phosphorylation i response to phorbol 
ester. Using a combination of hydroxylapatite chromatography and immunoblot with isotype-specific antibodies, we identified PKC-a, 
-~, -e, and -4 as the isotypes expressed in PC12 cells. A two-dimensional immunoblot approach was then developed to measure the 
changes in the phosphorylation state of PKC-et before and after exposure of intact PC12 cells to phorbol ester. We found a pool of four 
differentially migrating PKC-cx forms in untreated cells, which undergoes an acidic shift after phorbol ester. Furthermore, a similar shift 
in the two-dimensional immunoblot profile of PKC-ct was the result of the enzyme autophosphorylation upon in vitro treatment with a 
combination of phosphatidylserine and phorbol ester, an effect which was enhanced by co-application of purified bovine lung 
cGMP-dependent protein kinase-I (PKG-I). These results demonstrate a multiple phosphorylation of PKC-ct in untreated PC 12 cells and 
suggest hat various levels of autophosphorylation and trans-phosphorylation f this isoenzyme may occur in response to phorbol ester. 
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1. Introduction 
Protein kinase C (PKC) is a serine/threonine protein 
kinase playing a central role in the signalling mechanism 
initiated by a variety of extracellular agents, including 
hormones, neurotransmitters and growth factors [ 1,2]. Three 
distinct groups of isoenzymes, designated cPKCs (conven- 
tional forms, including PKC-e~, -[3I, -[3II, and -~), nPKCs 
(novel forms) and aPKCs (atypical forms), have been 
identified on the basis of similarity in the sequences and 
functional properties [3]. PKC is the major intracellular 
target for a class of potent umor promoters, called phorbol 
esters [4], which alter the function of PKC by modulating 
Abbreviations: cPKC, conventional protein kinase C isotype; DE-52, 
diethylaminoethyl cellulose; DTT, dithiothreitol; PKC, protein kinase C; 
PKG-I, cGMP-dependent protein kinase type I; PS, phosphatidyl-L-serine; 
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gelelectrophoresis; 
TPA, 12-O-tetradecanoyl-phorbol- 13-acetate. 
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both the intracellular location and cellular level of the 
enzyme. Such a dual effect is achieved via the intracellular 
redistribution of cytosolic PKC to the cell membranes [5], 
which is paralleled by kinase activation [6] and ultimately 
followed by down regulation due to an enhanced proteoly- 
sis [7]. 
The measurement of the PKC phosphorylation state is a 
potential index of kinase activation, as shown by the 
finding that compounds which stimulate PKC activity, 
either directly (e.g., phorbol esters) or indirectly (through 
mobilization of its activators), enhance the phosphorylation 
of PKC itself [8-13]. PKC is subject o autophosphoryla- 
tion and trans-phosphorylation, and both post-translational 
changes occur at multiple points in the activation cycle of 
the enzyme. The first step is a 'priming' phosphorylation 
which produces a characteristic retarded mobility of PKC 
on SDS-PAGE and appears to generate a protein kinase 
that is responsive to a variety of activators [14,15]. Further, 
the resulting activatable PKC can undergo additional stim- 
uli-dependent changes in phosphorylation [ 16-18]. In vitro, 
PKC autophosphorylation, as well as substrate phosphory- 
lation by PKC, is dependent upon the enzymes' exposure 
to activators uch as phosphatidylserine (PS), Ca 2+ and 
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1,2-diacylglycerol [19]. Autophosphorylation sites have 
been identified in distinct regions of PKC [18,20,21]. 
Under cell-free conditions and in the presence of its activa- 
tors, PKC has been reported to be trans-phosphorylated by 
several kinases, including casein kinase I [22], casein 
kinase II [23], $6 kinase [16] and cGMP-dependent protein 
kinase type I (PKG-I)[24]. In view of these observations, 
in intact cells each PKC isotype might be represented by a 
heterogenous population of phosphoforms with distinct 
repertoires of phosphorylation sites, whose stimulation po- 
tentially leads to distinct patterns of kinase activity. How- 
ever, the physiological relevance of the above data, most 
of which were only reported in vitro, is not yet fully 
understood [25]. 
In our effort to identify the functional role of late steps 
in the PKC multi-stage phosphorylation, we have previ- 
ously reported that the in vitro activation of a mix of 
cPKCs with a varying combination of Ca 2+, PS and 
phorbol ester induces distinct states of PKC autophospho- 
rylation [26]. Subsequently, we have demonstrated a corre- 
lation between phosphorylation sites and changes in the 
substrate specificity of PKC [27]. The present studies were 
undertaken to determine a correspondence between the 
phosphorylation state of PKC in intact cells and the in 
vitro autophosphorylation/trans-phosphorylation of puri- 
fied PKC. Taking advantage of the ability of the two-di- 
mensional immunoblot (2-D-immunoblot) procedure to po- 
tentially identify changes in protein phosphorylation as 
acidic shifts on a 2-D-gel [28], we focused our attention on 
PKC-a, the most extensively studied member of the PKC 
family. PC12 cells, a line derived from rat's pheochromo- 
cytoma, were used because they express PKC-~ isotype as 
the major, if not the only, isotype of the cPKC group. The 
results presented here indicate that in intact PC12 cells 
phorbol ester may promote autophosphorylation of PKC-a 
and its trans-phosphorylation by PKG-I. 
2. Materials and methods 
2.1. Cell culture 
PC12 cells were cultured in Dulbecco's modified 
Eagle's medium in the presence of 100 U/ml  penicillin 
and 0.1 mg/ml  streptomycin and supplemented with 5% 
foetal calf serum and 10% heat-inactivated horse serum. 
Cells were maintained in a 37°C incubator in a water- 
saturated atmosphere containing 7% CO 2. After plating, 
cells were grown for 48 h prior to use. 
2.2. Preparation of cell homogenates and DE-52 chro- 
matography 
Culture plates (90 mm) were placed on ice and washed 
three times with ice-cold 5 mM Tris-HC1, 5 mM MgCl 2, 
1.5 mM KC1, pH 7.4. All subsequent steps were carried 
out at 4°C. Cells were then scraped into lysis buffer (0.5 
ml/dish), containing 20 mM Tris-HCl, 5 mM EGTA, 1 
mM PMSF, 1 mM EGTA, 1% Triton X-100, 50 mM NaF. 
50 nM calyculin (Boehringer Mannheim), 10 p4 /ml  leu- 
peptin (pH 7.4), and then lysed with 10 passes through a 
26 gauge needle. Cell lysates were then centrifuged for 10 
min at 500 × g. The resulting pellet was discarded, while 
the supernatant (post-nuclear cell homogenate) was stored 
at -70°C. When indicated, post-nuclear cell homogenates 
were loaded onto a 2-ml diethylaminoethyl cellulose (DE- 
52, Whatman) column and equilibrated in 20 mM Tris-HCl 
(pH 7.5), 0.5 mM EGTA, 0.5 mM EDTA and 1 mM 
dithiothreitol (DTT). After washing with 15 column vol- 
umes of the equilibration buffer PKC was eluted with 5 
column volumes of the same buffer supplemented with 
300 mM NaC1 (flow rate 1 ml/min). 
2.3. Separation of cPKCs via hydroxylapatite chromatog- 
raphy 
The eluate from DE-52 chromatography was dialysed 
overnight at 4°C against 20 mM potassium phosphate 
buffer (pH 7.4), containing 0.5 mM EGTA, 0.5 mM 
EDTA and 1 mM DTT. The dialysate was applied to a 
hydroxylapatite column (0.78 X 10 cm, type S, Koken, 
Japan) connected to a Pharmacia FPLC system and equili- 
brated in the dialysis buffer supplemented with 10% glyc- 
erol. PKC was eluted by application of an 84-ml linear 
concentration gradient of potassium phosphate (20 mM-  
180 mM) in the presence of 0.5 mM EGTA, 0.5 mM 
EDTA, 1 mM DTT and 10% glycerol at a flow rate of 0.4 
ml/min. Each fraction (1 ml) was monitored for 
[ 3 H]phorbol 12,13-dibutyrate ([ 3H]PDBu) binding activity. 
2.4. [3H]PDBu binding assay 
Incubation with 20 nM [3H]PDBu (New England Nu- 
clear) was carried out in 20 mM Tris-HC1, pH 7.4 supple- 
mented with 1 mM EGTA and 0.75 mM CaC12, 1% (v/v)  
dimethysulphoxide, 2 mg/ml  bovine serum albumin, 0.1 
mg/ml  bath-sonicated PS. A modified version of the 
centrifuge column procedure originally designed by Penef- 
sky [29] was used to separate free from bound [3H]PDBu, 
as previously described [30]. Briefly, 2-ml plastic syringes 
were fitted with a porous polyethylene disc (0.75 mm 
thick, 30-50 ~m pore size) and filled with 2 ml of 
Sephadex G-50 previously swollen in 20 mM Tris-HC! pH 
7.4 and maintained in 10% excess buffer. Prior to use, 
columns were spun at 150 X g for 1 min to remove xcess 
buffer from the Sephadex bed. After incubation, samples 
were applied to G-50 columns and centrifuged at 150 X g 
for 5 min. Radioactivity in the eluate was counted after 
mixing with 4 ml of scintillation fluid. Specific binding 
represents he difference between binding measured in the 
absence (total binding) and presence (non-specific binding) 
of 20 p~M 12-O-tetradecanoyl-phorbol- 13-acetate (TPA). 
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2.5. SDS-PAGE and 2-D-electrophoresis 
When indicated, samples were subjected to elec- 
trophoresis on 7.5% SDS-PAGE [31], 2-D-electrophoresis 
was carried out as described [32], with the following 
minimal modifications. DE-52-eluted samples were diluted 
1:1 with buffer for isoelectric focusing (9.5 M urea. 5% 
CHAPS, 5% [3-mercaptoethanol and Pharmacia Ampho- 
lines as a mix of 1.8% pH :5-8, 0.2% pH 3-10) and solid 
urea (1 mg/i.zl) was dissolved in the sample buffer. 
Aliquots (50-100 ill) were loaded onto 7.5-cm long iso- 
electric focusing gel tubes (0.2 cm internal diameter) and 
resolved by isoelectric focusing (7000 V-hrs) in the first 
dimension. The second dimension was run as 10% SDS- 
PAGE on a Bio-rad minigel. 
2.6. hnmunoblot 
Proteins from SDS-PAGE and 2-D-electrophoresis were 
electrophoretically transfenred onto nitrocellulose mem- 
brane [33]. The nitrocellulose was blocked with 
phosphate-buffered saline (PBS) containing 1 
polyvinylpyrrolidone-40000 and incubated with the pri- 
mary antibody in PBS. The following primary antibodies 
were used at the indicated 'working concentrations: mouse 
monoclonal anti-protein F'KC-e~ (MC5, Amersham: 1 
txg/ml: Transduction Laboratories: 0.15 I, zg/ml), mouse 
monoclonal anti-protein and-PKC-13 (Seikagaku America, 
0.6 txg/ml), mouse monoclonal anti-protein anti-PKC-'y 
(Chemunex, I I-tg/ml) and rabbit anti-peptide anti-PKC-& 
-e and -;; (Gibco, 5 I~g/ral). Immunoreactivity was de- 
tected with peroxidase-conjugated s condary antibodies 
(Dakopatts) using the ECL method, following the Amer- 
sham instructions. In some blots, immunoreactive proteins 
were visualized with a solution containing 0.5% (w/v)  
cobaltous chloride, 0.025% (w/v) 3,3'-diaminobenzidine 
and 0.06% (v/v)  hydrogen peroxide. Note that the Amer- 
sham MC5 antibody, which is known to react strongest 
with PKC-o~ amongst all cPKCs [34], in our hands does 
not recognize any isotype other than PKC-oL (as shown in 
Fig. 2). 
2.7. Purification qf protein kinases 
When indicated, rat braiin cPKCs were purified to ho- 
mogeneity, as previously described [35], using Ca2+-de - 
pendent membrane binding prior to Q-sepharose high per- 
formance chromatography, a second Q-sepharose column 
in the presence of MgATP and phenyl-Sepharose chro- 
matography. In some experiments cPKCs were isolated 
from sheep brain instead of rat brain, with no apparent 
difference in the resulting preparation. Bovine lung 
cGMP-dependent protein kinase-I was purified to homo- 
geneity using DE-52, cAMP-affinity and Mono-Q column 
chromatographies, a  previously described [36]. The cat- 
alytic subunit of cAMP-dependent protein kinase (PKA) 
was purified from bovine heart as previously described 
[36]. 
2.8. h7 citro phosphoo'lation of PKC-a 
In vitro autophosphorylation and trans-phosphorylation 
of PKC-o~ was carried out in an incubation mixture (final 
volume of 80 ILl per tube) containing 30 mM Tris-HC1 
(pH 7.4), 1 mM EGTA, 1 mM MgSO4, 40 ILM ATP. 
When indicated, the following compounds were added at 
the indicated final concentration: PS (40 ~g/ml).  TPA (I 
I-tM), protamine sulfate (40 ~g/ml). histone III-S (800 
ILg/ml) and cGMP (10 ~M). Approximately 50 ng of a 
mix of purified cPKCs was added to each tube. When 
examining trans-phosphorylation of PKC-a by other ki- 
nases, PKG-I or the catalytic subunit of PKA were present 
at 20 ng per tube. Reactions were terminated after 10 min 
of incubation at 30°C by adding equal volumes of isoelec- 
trofocusing buffer and then solid urea (160 mg/tube), 
followed by through mixing. 
3. Results 
3.1. PKC expression in PCI2 cells 
To characterize the regulation of the PKC phosphoryla- 
tion state in PC12 cells, it was important to establish the 
identity of the isotypes expressed in these cells. This was 
determined with a combination of biochemical and im- 
munological approaches. Firstly. we employed an estab- 
lished chromatography scheme which typically separates 
the cPKCs expressed in rat brain [37]. Cell homogenates 
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Fig. 1. Elution profile of hydroxylapatite column. Cell homogenatcs from 
rat brain and PC12 cells were subjected to DE-52 and hydroxylapatite 
(HA) column chromatographies. An aliquot of the hydroxylapatite-eluted 
fractions was assayed tbr [3H]PDBu binding activity via the centrifuge 
column procedure, as described in the Section 2. Results are expressed as 
specific binding data. Similar column profiles were obtained in two 
additional experiments. 
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from rat brain and PC12 cells were subjected to sequential 
chromatography on DE-52 and hydroxylapatite columns 
(Fig. 1). Using rat brain and [3H]PDBu binding assay to 
evaluate the expression of phorbol ester sensitive PKC 
isotypes, three distinct peaks of binding activity are re- 
solved according to the previously reported order of elu- 
tion [20]: peak I (PKC-~/), peak II (PKC-13) and peak III 
(PKC-et). Cell homogenates from untreated PC12 cells 
exhibited a single major peak of activity, whose elution 
profile corresponded to peak III of rat brain (PKC-e~). 
Interestingly, [3H]PDBu binding activity of the hydroxyl- 
apatite fractions was found to co-elute with PKC kinase 
activity (A. Gatti, unpublished results). 
The identity of each hydroxylapatite peak extracted 
from rat brain was confirmed by immunoblot analysis with 
monospecific anti-PKC antibodies (Fig. 2). The blot of 
each rat brain hydroxylapatite p ak with anti-PKC-a, anti- 
PKC-[3 and anti-PKC-~ antibodies howed the recognition 
of a major immunoreactive band with the third, the second 
and the first peak, respectively. The anti-PKC antibody 
from Amersham (MC5) recognized only the third hydrox- 
ylapatite peak isolated from rat brain, indicating that under 
our experimental conditions MC5 specifically detects the 
PKC-a isotype. 
Comparative immunoblot analysis of crude cell ho- 
mogenates from PC12 cells with monospecific antibodies 
(Fig. 3) indicated that immunoreactive species belonging 
to the distinct groups of PKC isotypes are present in these 
cells: -e~ (cPKCs), -~, -e (nPKCs) and -~ (aPKCs). In 
contrast, neither PKC-I3 nor PKC-~/ isotype was detected 
with the respective isotype-specific antibody (data not 
shown). The specificity of the immunorecognition was 
confirmed by parallel immunoblot in the presence of an 
excess of the antigen against which the respective antibody 
was raised (data not shown). Overall, the combination of 
column chromatographies and immunoblot analyses re- 
anti-  e~ anti-  I~ ant/: 7 
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Fig. 2. Immunoblot analysis of hydroxylapatite-isolated active peaks from 
rat brain. Tissue homogenates of rat brain were subjected to DE-52 and 
hydroxylapatite column chromatographies, as described in Section 2. 
Fractions were assayed for [3H]PDBu binding activity and active frac- 
tions from each peak were pooled. Lanes 1, 2 and 3 correspond to the 
first, second and third hydroxylapatite peaks, respectively. An equal 
volume of each pool was subjected to 7.5% SDS-PAGE and immunoblot 
analysis with the following monoclonal anti-PKC antibodies: anti-PKC-~ 
(MC5) from Amersham, anti-PKC-13 and anti-PKC-% Immunoreactivity 
was detected with peroxidase-conjugated s condary antibody and finally 
visualized with a solution containing diaminobenzidine and hydrogen 
peroxide. The position of PKC is indicated on the right. Results shown 
are representative of three independent experiments. 
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Fig. 3. Immunoblot of PKC isotypes expressed in PCI2 cells. An aliquot 
of 50 Ixg protein from PC12 cell homogenate was subjected to 7.5% 
SDS-PAGE following by immunoblot analysis with anti-PKC-a (lane 1), 
anti-PKC-~ (lane 2), anti-PKC-~ (lane 3) and anti-PKC-i~ (lane 4) anti- 
bodies. Immunorecognition was carried out as described in legend to Fig. 
2. The migration of molecular weight markers is indicated on the left. 
Results shown are representative of three independent experiments. 
vealed four PKC isotypes to be basally expressed in PC12 
cells, of which only one (PKC-a) belongs to cPKCs. 
3.2. In situ phosphorylation of PKC-ce 
We next examined the possibility of identifying differ- 
entially phosphorylated PKC-a species in PC12 cells and 
to study their response to cell treatment with phorbol ester. 
DE-52-extracts from cell homogenates of PC12 cells were 
subjected to the 2-D-immunoblot procedure with two dis- 
tinct monoclonal anti-PKC-a antibodies, the Amersham 
MC5 antibody (Fig. 4, panel A and B) and the antibody 
supplied from Transduction Labs. (Fig. 4, panel C and D). 
Untreated PC12 cells (panel A and C) exhibited at least 
four distinct immunoreactive PKC-e~ species, consisting of 
closely migrating forms with an approximate isoelectric 
point ranging from 6 to 6.5. On the basis of the separation 
resulting from the first dimension of 2-D-electrophoresis 
(difference in molecular charge), the phosphorylation de- 
gree of each form increases from the basic to the acidic 
end, and the immunoreactive spots were designated a,b, c, 
etc. according to an increasing order of phosphorylation. 
Upon 20 min of cell incubation with 200 nM TPA 
(panel B and D) a shift in the rank order of PKC-a 
immunostaining intensity resulted in an apparent reduction 
of spot a and concomitant accumulation of more acidic 
spots. A similar 2-D-immunoblot picture of this effect was 
obtained with either anti-PKC-a antibody, except hat the 
most basic form (spot a) is preferentially recognized by the 
Amersham antibody and the more acidic species (spots 
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Fig. 4. Two-dimensional immunoblot of PKC-~ upon phorbol ester treatment of intact PCI2 cells. Before cell lysis, PCI2 cell cultures were incubated for 
20 min at 37°C in culture medium, in the presence or absence of 200 nM TPA. Postnuclear homogenates from untreated (panels A and C) and TPA-treated 
cells (panels B and D) were subjerted to DE-52 chromatography. The eluate from DE-52 column was diluted in buffer for the first dimension and resolved 
by isoelectric focusing (7000 V-hrs). After the second dimension in 10% SDS-PAGE, proteins were electrophoretically transferred to a nitrocellulose 
membrane and immunorecognitioa w s carried out with two commercially available monoclonal anti-PKC-~x antibodies: MC5 from Amersham (panels A 
and B) and an antibody from Transduction Labs. (panels C and D). Immunoreactive forms were visualized with the ECL detection system, as described in 
the manufacturer's instructions. Only the relevant sections of the X-ray films (corresponding to the pH range 5-8) are shown. Arrows indicate PKC-a 
forms that were clearly resolved and designated as a, b, c, etc. according to an increasing degree of phosphorylation. The migration of molecular weight 
markers is indicated on the right. Results shown are representative of three independent experiments. 
f-h) are exclusively detected by the antibody supplied by 
Transduction Labs. 
3.3. In uitro phosphorylation fPKC-a 
We next investigated the nature of the multiple phos- 
phorylation PKC-oL by examining the effects of its in vitro 
autophosphorylation and trans-phosphorylation. A sample 
of untreated purified PKC (comprising a mix of cPKCs) 
was subjected to 2-D-immunoblot and at least six differen- 
tially phosphorylated PKC-a species were detected with 
either anti-PKC-a antibody, from Amersham (panel A of 
Fig. 5) or from Transduction Labs. (panel A of Fig. 6). 
Note that when a mix of aliquots of purified PKC and in 
situ treated samples was analysed by 2-D-immunoblot the 
corresponding PKC-cx immunoreactive forms (i.e., spots 
designated with the same letter) were found to co-migrate 
(data not shown). 
To ascertain whether PKC-c~ autophosphorylation c uld 
produce a detectable mobility change in the 2-D-im- 
munoblot experimental system, purified PKC was exposed 
to two distinct conditions known to stimulate autophospho- 
rylation. Protamine, an arginine-rich substrate of PKC, was 
firstly used since it does not require the presence of 
cofactors/activators to induce PKC autophosphorylation 
[38]. Purified PKC was incubated with protamine sulfate 
(40 I~g/ml) and histone III-S (800 i~g/ml), whose co-ap- 
plication was reported to maximize PKC autophosphoryla- 
tion [39]. As shown in panel B of Figs. 5 and 6, the PKC-a 
immunoreactive forms respond to this combination of pro- 
tamine and histone with an acidic shift in the 2-D-ectro- 
phoretic profile and an accumulation of spots e-g. 
To examine the activator-dependent au ophosphoryla- 
tion of PKC-a, we next incubated purified PKC with a 
combination of PS and phorbol ester (PS/TPA). Under 
these conditions, phosphorylation f PKC-c~ was signifi- 
cantly increased, as revealed by either antibody (panel C of 
Figs. 5 and 6). As a result of this autophosphorylation, the 
balance of the entire pool of immunoreactive PKC-a 
species is shifted towards the acidic end with a concomi- 
tant reduction of the most basic form (spot a). 
Finally, we investigated whether in vitro PKC-e~ under- 
goes trans-phosphorylation by the catalytic subunit of 
PKA or the purified bovine lung PKG-I. In the absence of 
PS/TPA both these protein kinases failed to produce an 
apparent increase in PKC-a phosphorylation (data not 
shown). However, the PS/TPA-dependent shift in the 
2-D-immunoblot profile of PKC-o~ was significantly en- 
hanced by the co-application of PKG-I, as visualized by an 
accumulation of spots e-h (panel D of Figs. 5 and 6). The 
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use of two distinct anti-PKC-o~ antibodies demonstrated 
that the activated form of PKC-o~ is a substrate for PKG-I. 
In contrast, there was no increase in PKC-o~ phosphoryla- 
tion by the co-application of catalytic subunit of PKA 
together with PS/TPA (data not shown). 
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Fig. 5. In vitro autophosphorylation and trans-phosphorylation of PKC-o~. 
as assessed by two-dimensional immunoblot with the antibody from 
Amersham. An equal amount of PKC (apprx. 50 ng) was incubated in 30 
mM Tris-HCl (pH 7.4). I mM EGTA. I mM MgSO 4. 40 p.M ATP for 10 
rain at 30°C in the absence of additional agents (panel A) or in the 
presence of the following: 40 ~zg/ml protamine sulfate plus 800 ~zg/ml 
histone III-S (panel B). 40 ~tg/ml PS plus 1 p~M TPA (panel C), 40 
p.g/ml PS. 1 ~M/ml  TPA. 10 ixM cGMP and 20 ng of bovine lung 
purified PKG-I (panel D). After 2-D-electrophoresis. proteins were trans- 
ferred to a nitrocellulose membrane and PKC-cx immunoreactivity was 
analysed with the Amersham antibody MC5. as described in the legend to 
Fig..4. Only the relevant sections of the X-ray films (corresponding to the. 
pH range 5-7) are shown. The position of PKC-c~ is indicated on the 
right, Similar results were obtained in two additional experiments. 
Contro l  P ro ta l l l i l ]e  
A B 
b d f b d. f 
4 ,4 ,¢  4 ,4 ,¢  
a c e a c eg  
- -  SO kDa 
PS/TPA PS/TPA/PKG 
D 
b d f b d f h 
4,44 ,  4 ,4 ,4 ,  4, 
a c e g a c e g 
- -  80 kDa 
I i 
7 ;;H 5 7 pH 5 
Fig. 6. In vitro autophosphorylation andtl~ms-phosphorylation of PKC-cx. 
as assessed by two-dimensional immunoblot with the antibody from 
Transduction Labs. Conditions were the same as in Fig. 5. except hat 
here the primary anti-PKC-a antibody was from Transduction Labs. The 
position of PKC-a is indicated on the right. Similar results were obtained 
in two additional experiments. 
4. D iscuss ion 
The extent of PKC phosphorylation has been proposed 
to represent an useful criterion of its activation state 
[8.11,12], and the in vitro ability of PKC to autophosphory- 
late has been linked to the occurrence of PKC activation in 
intact cells [9,13]. However, it is not yet established whether 
exposure of intact cells to activators uch as phorbol ester 
induces PKC autophosphorylation or its trans-phosphory- 
lation by other kinases. To address this question we estab- 
lished an experimental system based on the comparison of 
in situ and in vitro models of PKC phosphorylation. We 
firstly documented the expression of four distinct PKC 
isotypes in PC I2 cells by using a combination of biochem- 
ical and immunochemical pproaches. Our results are in 
good agreement with previous studies of PKC expression 
in these cells [40,41]. Given that PKC-o~ is the major, if 
not the only, isotype of the group of cPKCs present in 
PC I2 cells, we next developed a 2-D-immunoblot proce- 
dure to monitor the state of PKC-ot phosphorylation. This 
approach allowed us to detect a phorbol ester-mediated 
increase in PKC-a phosphorylation, both with in situ and 
in vitro systems. Such a phosphorylation change was as- 
sessed as an acidic shift in the ratio of differentially 
phosphorylated PKC-cx forms, as visualized by a substan- 
tial reduction in the most basic form in concomitance to an 
accumulation of more acidic forms. It should be noted that 
since the relative affinity of the two antibodies versus 
differentially phosphorylated PKC-o~ forms is not known, 
the intensity of the immunoreactive spots does not neces- 
sarily reflect the respective protein abundance. However, 
the combined use of two distinct anti-PKC-c~ antibodies 
provided strong evidence for an involvement of most 
PKC-oL forms in the phorbol ester-mediated phosphoryla- 
tion events. Further, upon exposure to phorbol ester many 
of the PKC-cx phosphoforms of treated PCI2 cells appear 
to co-migrate with the in vitro treated rat brain PKC-~x 
forms, substantiating the possibility that phorbol ester in 
vivo causes PKC-e~ autophosphorylation. The large num- 
ber of PKC-oL phosphoforms detected in purified enzyme 
from rat brain can be explained by the selectivity of the 
purification procedure used to isolate cPKCs (see Section 
2). This is likely to maximize the recovery of phosphory- 
lated PKC-cx forms at the expense of unphosphorylated, 
non-primed forms. 
In a preliminary communication, we have previously 
described the in vitro phosphorylation of a mixture of 
cPKCs by PKG-I [24]. In the present paper, the acidic shift 
of PKC-o~ occurring upon in vitro PS/TPA-induced auto- 
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phosphorylation was found to be enhanced by the co-appli- 
cation of PKG-I. Given that the activator-dependent auto- 
phosphorylation and trans-phosphorylation of activated 
PKC-a are not mutually exclusive mechanisms, the sim- 
plest interpretation f these results is that upon exposure to 
phorbol ester PKC-c~ undergoes autophosphorylation and 
possibly trans-phosphorylation by protein kinases such as 
PKG-I. If confirmed by in vivo data, the trans-phosphory- 
lation of activated PKC-c~ by PKG-I would represent an 
important point of cross-talk between the cGMP-mediated 
and Ca2-/diacylglycerol-mediated signalling pathways. 
However, the data presented here cannot yet fully rule out 
the possibility that in intact cells phorbol ester induces an 
endogenous protein kinase, other than PKA or PKG-I, to 
phosphorylate PKC-c~ in a permissive vent prior to PKC-a 
autophosphorylation. 
The 2-D-immunoblot procedure also allowed the detec- 
tion of activator-independent autophosphorylation of PKC- 
a, as shown upon cell-free treatment of purified PKC with 
protamine sulfate that is known to cause PKC autophos- 
phorylation in the absence of activators. The comparison 
between activator-dependent a d -independent autophos- 
phorylation of PKC-e~ suggests that the effects of in vitro 
treatment with protamine sulfate or with PS/TPA are not 
fully equivalent. This can be largely explained by a differ- 
ential extent of PKC-a autophosphorylation. Interestingly, 
positively charged agents uch as poly-t.-arginine and pro- 
tamine are unable to stimulate the phosphorylation of 
conventional substrates by PKC, in spite of inducing its 
autophosphorylation [38,39]. The discrepancy between pro- 
tamine-mediated and PS/TPA-mediated changes in the 
phosphorylation state of PKC-a may therefore xplain 
why the activator-dependent au ophosphorylation of PKC 
is indicative of full activation and the activator-indepen- 
dent event is not. 
A number of technical difficulties in detecting the phos- 
phoforms of any single PKC isotype have traditionally 
precluded the analysis of the correspondence b tween in 
situ PKC activation and changes in its state of phosphory- 
lation. In contrast o the presence of a large number of 
phosphorylatable residues in individual isotypes [21], only 
one or two forms of mature PKC have been routinely 
detected, regardless the ,ase of phosphatases or kinases 
[ 14,17,42,43]. This is due to the limited number of changes 
in PKC phosphorylation state that can be visualized as 
mobility shifts on SDS-PAGE. In the present study, the 
2-D-immunoblot procedure reveals the presence of several 
differentially phosphorylated PKC-a species as co-ex- 
pressed forms in untreated PC I2 cells. The multiple phos- 
phorylation of PKC-c~ might reflect the potential to elicit 
differential responses from distinct phosphoforms to any 
given stimulus. This phenomenon is likely to represent a
further level of PKC functional diversity in addition to the 
well-known sources of heterogeneity such as isotype- 
specific tissue distribution and intracellular localization. 
This new approach may be used to reveal new insights 
into the response of other PKC isoenzymes under different 
stimuli and to elucidate the role of phosphorylation changes 
in the regulation of the multifunctional ctivity of PKC. It 
is conceivable that changes in the phosphorylation state 
will be correlated to a number of functional aspects of 
PKC activity, including intracellular edistribution, sub- 
strate specificity and down regulation. 
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